Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Perinatal Medicine

Official Journal of the World Association of Perinatal Medicine

Editor-in-Chief: Dudenhausen, MD, FRCOG, Joachim W.

Editorial Board Member: / Bancalari, Eduardo / Greenough, Anne / Genc, Mehmet R. / Chervenak, Frank A. / Chappelle, Joseph / Bergmann, Renate L. / Bernardes, J.F. / Bevilacqua, G. / Blickstein, Isaac / Cabero Roura, Luis / Carbonell-Estrany, Xavier / Carrera, Jose M. / D`Addario, Vincenzo / D'Alton, MD, Mary E. / Dimitrou, G. / Grunebaum, Amos / Hentschel, Roland / Köpcke, W. / Kawabata, Ichiro / Keirse, Marc J.N.C. / Kurjak M.D., Asim / Lee, Ben H. / Levene, Malcolm / Lockwood, Charles J. / Marsal, Karel / Makatsariya, Alexander / Nishida, Hiroshi / Papp, Zoltán / Pejaver, Ranjan Kumar / Pooh, Ritsuko K. / Reiss, Irwin / Romero, Roberto / Saugstad, Ola D. / Schenker, Joseph G. / Sen, Cihat / Seri, Istvan / Vetter, Klaus / Winn, Hung N. / Young, Bruce K. / Zimmermann, Roland

9 Issues per year


IMPACT FACTOR 2016: 1.577
5-year IMPACT FACTOR: 1.705

CiteScore 2016: 1.49

SCImago Journal Rank (SJR) 2016: 0.602
Source Normalized Impact per Paper (SNIP) 2016: 0.832

Online
ISSN
1619-3997
See all formats and pricing
More options …
Volume 28, Issue 5 (Sep 2000)

Issues

Administration of interferon-α during pregnancy: effects on fetus

Mitsuhiro Hiratsuka / Hisanori Minakami / Shiro Koshizuka / Ikuo Sato
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/JPM.2000.047

Abstract

Interferon-α (IFα) is used for the treatment of myeloproliferative diseases and chronic viral illnesses. Because the agent has antiproliferative activity, its effects on a fetus are a concern. We encountered a 40-year-old Japanese woman who inadvertently received IFα during pregnancy for the treatment of HCV hepatitis. The patient received 5 million units of IFα 2 to 4 times per week (total dose of 315 million units) between 13 and 33 weeks gestation. The patient delivered a normally formed healthy male infant, weighing 2,252 g at 37 weeks of gestation. The infant at 20-month-old exhibited normal growth and neurological development when last examined. Literatures were reviewed to determine the effects of IFα on the fetus. There have been 27 infants born to 26 mothers, including the present case, who were exposed to IFα in utero. Six women (23%) were administered IFα inadvertently during pregnancy. Four women (15%) gave birth prematurely. Although 6 infants (22%) were affected by intrauterine growth retardation (IUGR), there were no IFα-related malformed infants. These results suggested that an inadvertent administration of IFα during pregnancy may occur, but in that case IFα may not induce congenital malformations. These findings may encourage such women to continue pregnancy.

About the article

Published Online: 2005-06-01

Published in Print: 2000-09-20


Citation Information: Journal of Perinatal Medicine, ISSN (Print) 0300-5577, DOI: https://doi.org/10.1515/JPM.2000.047.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Noel M Lee and Carla W Brady
World Journal of Gastroenterology, 2009, Volume 15, Number 8, Page 897
[2]
L. S. Al-radi, T. N. Moiseeva, S. Yu. Smirnova, and R. G. Shmakov
Terapevticheskii arkhiv, 2017, Volume 89, Number 7, Page 99
[3]
Marianne Pavel, Juan W. Valle, Barbro Eriksson, Anja Rinke, Martyn Caplin, Jie Chen, Frederico Costa, Jenny Falkerby, Nicola Fazio, Vera Gorbounova, Wouter de Herder, Matthew Kulke, Catherine Lombard-Bohas, J. O'Connor, Halfdan Sorbye, and Rocio Garcia-Carbonero
Neuroendocrinology, 2017
[4]
Latifa TF Yeung and Eve A Roberts
Paediatrics & Child Health, 2001, Volume 6, Number 9, Page 655
[5]
M Michieli, FA Peccatori, A Lleshi, L Del Pup, D Valente, M Rupolo, U Tirelli, and M Berretta
International Journal of Immunopathology and Pharmacology, 2012, Volume 25, Number 2_suppl, Page 21
[6]
Leo Doherty, Levent Mutlu, Donna Sinclair, and Hugh Taylor
Reproductive Sciences, 2014, Volume 21, Number 9, Page 1067
[7]
Ersan Özaslan, Rahmi Yılmaz, Halis Simsek, and Gonca Tatar
Annals of Pharmacotherapy, 2002, Volume 36, Number 11, Page 1715
[8]
M Berretta, R Di Francia, A Lleshi, P De Paoli, G Li Volti, A Bearz, L Del Pup, U Tirelli, and M Michieli
International Journal of Immunopathology and Pharmacology, 2012, Volume 25, Number 2_suppl, Page 1
[9]
L Del Pup, F Peccatori, Hajr Azim, M Michieli, M Moioli, G Giorda, U Tirelli, and M Berretta
International Journal of Immunopathology and Pharmacology, 2012, Volume 25, Number 2_suppl, Page 33
[10]
Arjun Datt Law, Dennis Dong Hwan Kim, and Jeffrey Howard Lipton
Leukemia & Lymphoma, 2017, Volume 58, Number 2, Page 280
[11]
Elisabetta Abruzzese, Malgorzata Monika Trawinska, Paolo de Fabritiis, and Michele Baccarani
Expert Review of Hematology, 2016, Volume 9, Number 8, Page 781
[12]
Halil Ibrahim Atasoy, Pinar Sirmatel, and Fatma Sirmatel
The Journal of Maternal-Fetal & Neonatal Medicine, 2017, Volume 30, Number 6, Page 745
[13]
Mahender Yellu, Sue Pinkard, Abhimanyu Ghose, and Stephen Medlin
Transfusion and Apheresis Science, 2015, Volume 53, Number 3, Page 289
[14]
Renuka Palani, Dragana Milojkovic, and Jane F. Apperley
Annals of Hematology, 2015, Volume 94, Number S2, Page 167
[15]
Noa Lavi, Netanel A Horowitz, and Benjamin Brenner
Women's Health, 2014, Volume 10, Number 3, Page 255
[16]
S. Boussios and N. Pavlidis
Clinical and Translational Oncology, 2014, Volume 16, Number 2, Page 122
[17]
Tsung-Ying Hsieh, Chen-Hsiang Yu, Pao-Lin Kuo, and Fong-Ming Chang
Taiwanese Journal of Obstetrics and Gynecology, 2006, Volume 45, Number 2, Page 180
[18]
P. Yazdani Brojeni, I. Matok, F. Garcia Bournissen, and G. Koren
Reproductive Toxicology, 2012, Volume 33, Number 3, Page 265
[19]
Sabela Paradela-de la Morena, Carmen Peña-Penabad, and Eduardo Fonseca-Capdevila
Piel, 2005, Volume 20, Number 7, Page 317
[20]
Deborah M Money
Obstetrics and Gynecology Clinics of North America, 2003, Volume 30, Number 4, Page 731
[21]
Catherine Williamson
Best Practice & Research Clinical Obstetrics & Gynaecology, 2001, Volume 15, Number 6, Page 937
[22]
E. Voulgaris, G. Pentheroudakis, and N. Pavlidis
Surgical Oncology, 2011, Volume 20, Number 4, Page e175
[24]
Tal Shapira, David Pereg, and Michael Lishner
Blood Reviews, 2008, Volume 22, Number 5, Page 247
[25]
Marie-Cécile Valera, Olivier Parant, Christophe Vayssiere, Jean-François Arnal, and Bernard Payrastre
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011, Volume 158, Number 2, Page 141
[26]
Uma Mahadevan
Best Practice & Research Clinical Gastroenterology, 2007, Volume 21, Number 5, Page 849
[29]
Makarand V. Khochikar
Nature Reviews Urology, 2010, Volume 7, Number 4, Page 195
[30]
Tina Rizack, Anthony Mega, Robert Legare, and Jorge Castillo
American Journal of Hematology, 2009, Volume 84, Number 12, Page 830
[31]
Melinda Fritz, Kalyani Vats, and Rakesh K Goyal
Journal of Perinatology, 2005, Volume 25, Number 8, Page 552
[32]
Pharmacoepidemiology and Drug Safety, 2001, Volume 10, Number 2, Page 173
[33]
Prenatal Diagnosis, 2001, Volume 21, Number 3, Page 235

Comments (0)

Please log in or register to comment.
Log in